| Course | HW310 Complementary and Integrative Medicine |
|---|---|
| Unit | Unit 4 |
| Paper type | Supplement interaction analysis |
| Length | About 1,140 words, 7 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | BS in Health and Wellness |
| Updated | October 2026 |
Free sample paper for HW310 Unit 4
A Duplicate Statin in a Rice Capsule: A Unit 4 Supplement Interaction Analysis for a Client on Atorvastatin and Levothyroxine
[Student Name]
Purdue University Global
HW310: Complementary and Integrative Medicine
Unit 4 Supplement Interaction Analysis
[Instructor Name]
[Date]
The client, her medications and her supplement routine are composite; the interaction studies, product analysis and federal sources cited are real.
Client Summary
Renata, a composite 58-year-old office administrator, completed a wellness intake at her employer's health program. She takes two prescriptions: atorvastatin 20 mg each evening for high cholesterol and levothyroxine 75 micrograms each morning for an underactive thyroid. Over the past four months she has added three products. A coworker recommended red yeast rice as a "natural cholesterol helper," so she takes two capsules daily. She takes goldenseal capsules during the winter "for immunity." On her doctor's earlier advice about bone health, she bought a calcium carbonate supplement, which she takes with breakfast, at the same time as her thyroid pill, because it is easier to remember. She has not told her physician or pharmacist about any of the three.
Method
Every product appears on both axes of an interaction grid, prescriptions and supplements alike, so that supplement-to-drug and supplement-to-supplement pairs are both checked. Each pairing was looked up in federal fact sheets and in the published studies cited below and given one of three ratings: documented concern, meaning human data or a regulatory warning supports it; theoretical concern, meaning the mechanism is plausible but human evidence is limited; or none found in the references checked. A rating of none found is not a guarantee of safety.
The Interaction Grid
Each line below is one cell of the grid.
1. Red yeast rice with atorvastatin: documented concern. Duplicate therapy.
2. Goldenseal with atorvastatin: documented concern, moderate. Altered drug breakdown.
3. Calcium carbonate with levothyroxine: documented concern. Reduced absorption.
4. Red yeast rice with goldenseal: theoretical concern. Goldenseal could raise levels of the statin-like compound in red yeast rice.
5. Red yeast rice with levothyroxine: none found.
6. Goldenseal with levothyroxine: none found.
7. Calcium carbonate with atorvastatin: none found.
8. Calcium carbonate with red yeast rice or goldenseal: none found.
Three cells stand out, and each is examined below.
Red Yeast Rice and Atorvastatin
Red yeast rice is rice fermented with a yeast that produces compounds called monacolins. The main one, monacolin K, is chemically identical to lovastatin, a prescription statin (National Center for Complementary and Integrative Health [NCCIH], 2019). In practical terms, Renata may be taking two statins: one prescribed and measured, the other unmeasured.
The concern is the known risk of statins at higher combined exposure, chiefly muscle pain and, rarely, serious muscle injury. A trial in people who could not tolerate prescription statins found that red yeast rice lowered LDL cholesterol compared with placebo, which confirms that the product is pharmacologically active (Becker et al., 2009). A laboratory analysis of 12 commercial products, all labeled 600 milligrams per capsule, found monacolin K ranging from about 0.1 to 10 milligrams per capsule, a hundredfold difference, and found citrinin, a contaminant toxic to the kidneys in animals, in four products (Gordon et al., 2010). Renata therefore cannot know how much statin she is adding.
The most important finding of this analysis is not an interaction between two different substances but a duplication: a supplement sold for cholesterol contains a version of the very drug Renata already takes for cholesterol, in an amount no label discloses.
Evidence type: chemical identity of monacolin K and lovastatin, product analysis and a placebo-controlled trial of lipid effect. Who should review: her prescribing physician or pharmacist, who can decide whether the supplement should be stopped and whether her cholesterol results reflect both products.
Goldenseal and Atorvastatin
Many drugs, including atorvastatin, are broken down in the liver and gut by an enzyme known as CYP3A. In a study of 16 healthy volunteers, 14 days of goldenseal supplementation markedly slowed the breakdown of midazolam, a standard test drug for this enzyme, raising its total exposure by roughly 60 percent and lengthening its half-life (Gurley et al., 2008). If goldenseal slows CYP3A in the same way for atorvastatin, blood levels of the statin could rise, adding to the muscle concern above.
The evidence is documented for the enzyme but indirect for atorvastatin itself, since the study used a probe drug rather than a statin. The rating is therefore documented concern of moderate strength. The federal fact sheet on goldenseal notes its potential to interact with many medications for the same reason (NCCIH, 2020). Who should review: her pharmacist.
Calcium Carbonate and Levothyroxine
Levothyroxine is absorbed poorly when taken with certain minerals. In a study of 20 people on stable levothyroxine doses, taking 1,200 milligrams of calcium as calcium carbonate with the thyroid pill for three months lowered free thyroxine and raised thyroid-stimulating hormone, from an average of 1.6 to 2.7, and one in five patients rose above the normal range; levels recovered after the calcium was stopped (Singh et al., 2000). Laboratory work in the same study showed that thyroxine binds to calcium carbonate.
Renata takes the two together every morning. This is the easiest of the three concerns to address, since the usual approach is simply to separate the two by several hours, but the decision about timing belongs to her physician or pharmacist, who may also want to recheck her thyroid levels.
Why Renata Did Not Mention Them
Renata's silence is typical. Many people do not think of supplements as medicines, and products sold beside vitamins on a store shelf rarely look like something a doctor needs to know about. Red yeast rice in particular is marketed as natural, which led Renata to assume it could not overlap with her prescription. The analysis therefore treats asking about every product, in plain words, as part of the intervention, not a formality before it.
Lower-Concern Pairings
No interaction was found in the references checked between red yeast rice or goldenseal and levothyroxine, or between calcium carbonate and atorvastatin. Red yeast rice with goldenseal is rated theoretical: goldenseal's effect on CYP3A could raise levels of monacolin K, since lovastatin is also broken down by that enzyme, but no study has examined the pair.
Communication and Scope
A wellness professional's role is to identify these concerns, explain them clearly and refer. Renata should be encouraged to bring every bottle to her pharmacist or physician, and the professional can send a short summary with her consent. The analysis does not tell her to stop any product; that decision belongs to the clinicians who manage her prescriptions.
Limits
The analysis relies on federal fact sheets and a small number of human studies, some using probe drugs rather than the client's own medications. Product contents vary, so the actual dose of monacolin K and goldenseal's active compounds in Renata's bottles is unknown.
References
Becker, D. J., Gordon, R. Y., Halbert, S. C., French, B., Morris, P. B., & Rader, D. J. (2009). Red yeast rice for dyslipidemia in statin-intolerant patients: A randomized trial. Annals of Internal Medicine, 150(12), 830-839. https://doi.org/10.7326/0003-4819-150-12-200906160-00006
Gordon, R. Y., Cooperman, T., Obermeyer, W., & Becker, D. J. (2010). Marked variability of monacolin levels in commercial red yeast rice products: Buyer beware! Archives of Internal Medicine, 170(19), 1722-1727. https://doi.org/10.1001/archinternmed.2010.382
Gurley, B. J., Swain, A., Hubbard, M. A., Hartsfield, F., Thaden, J., Williams, D. K., Gentry, W. B., & Tong, Y. (2008). Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. Clinical Pharmacology & Therapeutics, 83(1), 61-69. https://doi.org/10.1038/sj.clpt.6100222
National Center for Complementary and Integrative Health. (2019). Red yeast rice. U.S. Department of Health and Human Services. https://www.nccih.nih.gov/health/red-yeast-rice
National Center for Complementary and Integrative Health. (2020). Goldenseal. U.S. Department of Health and Human Services. https://www.nccih.nih.gov/health/goldenseal
Singh, N., Singh, P. N., & Hershman, J. M. (2000). Effect of calcium carbonate on the absorption of levothyroxine. JAMA, 283(21), 2822-2825. https://doi.org/10.1001/jama.283.21.2822
The Purdue Global HW310 Unit 4 instructions
In the interaction analysis, students examine a client's full list of medicines and supplements and identify combinations that may cause problems. Prompts usually provide a scenario and ask for a systematic check, a rating of each concern, an explanation of the mechanism and evidence, and the professional who should review it. Put every product on both axes so supplement-to-supplement pairs are checked too. Define your rating levels before using them. Use reliable references such as federal fact sheets and published studies, and say when no data were found rather than implying safety. Explain mechanisms in plain language. Stay within scope: identify and refer, never instruct the client to stop or change a medicine. Four to six pages, often built around a grid or table, is common.
How the HW 310 Unit 4 example is put together
A client summary describes Renata's prescriptions, three added products and her habit of taking calcium with her thyroid pill. A method section defines three ratings. The grid follows as eight numbered lines, three flagged as documented concerns. The red yeast rice section explains that monacolin K is chemically identical to lovastatin, reports a placebo-controlled trial and a product analysis showing a hundredfold range in content, and the highlighted sentence names duplication as the main finding. Goldenseal is rated moderate because its evidence comes from a probe drug. The calcium section reports thyroid levels rising in one in five patients. A section explains why Renata never mentioned the products, and scope, referral and limits close the paper.
Reading the HW310 Unit 4 grading rubric
Interaction analysis rubrics in HW310 usually award the most points for identifying the significant concerns and explaining them accurately. A systematic method, shown by a full grid and defined ratings, is scored separately. Use of credible references, with the type of evidence named for each flag, earns points under evidence. Scope and referral are a major criterion: the analysis must direct decisions to physicians or pharmacists. Clarity matters because the work may be shared with a client. Citation in APA and correct terminology complete the marks. Analyses that miss a duplication or a well-documented absorption problem lose substantial points, and so do those that tell the client what to stop taking.
HW310 Unit 4 help: mistakes that cost points
Students often check only supplements against prescriptions and never look at supplements against each other. Another weakness is treating no data found as proof of safety. Some analyses list every theoretical concern with equal weight, burying the two or three that matter. Mechanisms are frequently described in jargon a client could not follow. The commonest scope error is advising the client to stop a product, which belongs to her prescriber. Product variation, a major issue for red yeast rice and many herbs, is often ignored. If your scenario lists products you cannot find in standard references, share the list and your prompt, and we will lay out every pairing on a grid with its evidence.
Get an HW310 Unit 4 example written to your instructions
Paste the client scenario exactly as the Unit 4 prompt gives it, every product and prescription included, together with any required reference list and the rubric. Each pairing is rated, with its evidence basis stated, and the concerns are routed rather than resolved. The analysis is back inside 24-48h, and a first sample is free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More HW310 papers and BS in Health and Wellness samples
- HW310 Unit 1: Personal Practice Post
- HW310 Unit 2: Modality Description Paper
- HW310 Unit 3: Acupuncture Evidence Review
- HW310 Unit 5: Mind-body Practice Evaluation
- HW310 Unit 6: Seminar Reflection
- HW310 Unit 7: Cultural Practice Analysis
- HW310 Unit 8: Integration Case Study
- HW310 Unit 9: Client Recommendation Memo
- HW310 Unit 10: Integrative Approach Portfolio
- HD499 Unit 4: Community Assessment Section
- HD480 Unit 4: Social Marketing Exchange Analysis
- HD460 Unit 4: Fidelity Monitoring Plan
- HD440 Unit 4: Priority Setting Matrix
HW310 Unit 4 questions, answered
Which references are best for checking supplement interactions?
Government summaries such as the NIH Office of Dietary Supplements fact sheets and NCCIH's herb pages are reliable starting points and free to access. Many university libraries also license a clinical interaction database, which gives ratings and the studies behind them. Product labels and retailer pages are useful only for confirming what the client actually takes, never for judging safety.
Can the analysis say whether the client should keep taking something?
Not in the sense of an instruction. A wellness analysis names the concern, explains the mechanism and the evidence, and sends the question to the prescriber or pharmacist, who can weigh the whole picture. Telling a client to drop or alter a prescribed medication crosses the scope line this course enforces, even when the flag itself is correct.
What if the client scenario includes a product I cannot find in any reference?
Report that, precisely. Name the references searched, state that no interaction data were found, and explain what that absence means: not that the product is safe, but that it has not been studied in combination. Proprietary blends with many ingredients are the usual case, and listing each ingredient separately often turns up information the brand name hides.
Where can I find a free HW310 Unit 4 sample paper?
This page presents a complete Unit 4 supplement interaction analysis for a client on atorvastatin and levothyroxine, with an eight-line grid, three flagged concerns and APA references.
Why is red yeast rice a concern with a statin?
Its main active compound, monacolin K, is chemically the same as lovastatin, so a client already on a statin may be adding a second one in an unknown dose.